Download in electronic PDF format for $25



Search the Complete Journal Archives

Stability of Vancomycin in SyrSpend SF

Author(s):  Whaley Paul A, Voudrie Mark A II

Issue:  Mar/Apr 2012 - Volume 16, Number 2
View All Articles in Issue

Abstract:  Vancomycin is administered orally for the treatment of pseudomembranous colitis induced by Clostridium difficile. Vancomycin is marketed for this purpose by ViroPharma as VANCOCIN in 125-mg and 250-mg capsules. The need for other dose form options for those patients who cannot take capsules has led compounding pharmacies to seek other alternatives, namely oral solutions and suspensions. Additionally, some patients are unable to use suspending agents containing alcohol or sorbitol. The objective of this study was to determine the stability of vancomycin in SyrSpend SF, a suspending agent containing neither sorbitol nor alcohol. The studied sample was compounded into a 50-mg/mL suspension and stored in a low-actinic plastic bottle at temperatures between 2oC and 8oC. Six samples were assayed at each time point out to 90 days by a stability-indicating high-performance liquid chromatography method. The method was validated for its specificity through forced-degradation studies. The sample remained within 90% to 110% of the initial concentration throughout the course of the study. Based on data collected, the shelf life of this product is at least 90 days when refrigerated and protected from light. Based on the final potency data at day 90, the beyond-use date may be longer, but 90 days was the limit of this study.

Related Keywords: Paul A. Whaley, BS, Mark A. Voudrie II, MS, PMP, vancomycin, antibiotic, pseudomembranous colitis, Clostridium difficile, suspension, stabiltiy

Related Categories: EXCIPIENTS, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, INFECTIOUS DISEASE, STORAGE

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Stability of Vancomycin in SyrSpend SF Whaley Paul A, Voudrie Mark A II Mar/Apr 2012 167-169 Buy
Stability of Omeprazole in SyrSpend SF Alka (Reconstituted) Whaley Paul A, Voudrie Mark A II, Sorenson Bridget Mar/Apr 2012 164-166 Buy
Stability of Gabapentin in SyrSpend SF Sorenson Bridget, Voudrie Mark A II, Gehrig Dan Jul/Aug 2012 347-349 Buy
Stability of Ursodiol in SyrSpend SF Cherry Flavored Geiger Christine M, Voudrie Mark A II, Sorenson Bridget Nov/Dec 2012 510-512 Buy
Stability of Propranolol Hydrochloride in SyrSpend SF Geiger Christine M, Voudrie Mark A II, Sorenson Bridget Nov/Dec 2012 513-515 Buy
Stability of Verapamil Hydrochloride in SyrSpend SF Compared to Sorbitol Containing Syrup and Suspending Vehicles Voudrie Mark A, Alexander Bridget, Allen D Brett May/Jun 2011 255-258 Buy
Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution) Voudrie Mark A II, Allen D Brett Jan/Feb 2010 82-85 Buy
Stability of Captopril in SyrSPend SF Geiger Christine M, Sorenson Bridget, Whaley Paul A Jul/Aug 2013 336-338 Buy
Stability of Midazolam in SyrSpend SF and SyrSpend SF Cherry Geiger Christine M, Sorenson Bridget, Whaley Paul A Jul/Aug 2013 344-346 Buy
Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF Geiger Christine M, Sorenson Bridget, Whaley Paul Sep/Oct 2015 420-427 Buy